Apogee Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
23 Aug 24 | SellUS$289,560 | Jane Pritchett Henderson | Individual | 6,000 | US$48.26 |
Insider Trading Volume
Insider Buying: APGE insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 1,182,460 | 1.66% |
Private Companies | 4,199,437 | 5.88% |
Hedge Funds | 4,762,558 | 6.67% |
VC/PE Firms | 15,236,642 | 21.3% |
Institutions | 46,021,324 | 64.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
15,236,642 | US$874.2m | 0% | 34.46% | |||
7,505,832 | US$430.7m | 11.3% | 0.03% | |||
4,814,400 | US$276.2m | 35.7% | 0.04% | |||
4,762,558 | US$273.3m | 0% | 19.39% | |||
2,975,917 | US$170.7m | 8.51% | no data | |||
2,712,096 | US$155.6m | 9.91% | 2.22% | |||
2,392,042 | US$137.2m | 29.8% | 6.53% | |||
2,259,073 | US$129.6m | 0% | no data | |||
2,117,870 | US$121.5m | 2.62% | 0.76% | |||
2,105,636 | US$120.8m | 2.2% | 2.48% | |||
1,970,320 | US$113.1m | 5.44% | no data | |||
1,961,863 | US$112.6m | -0.81% | 1.27% | |||
1,940,364 | US$111.3m | 0% | no data | |||
1,561,362 | US$89.6m | 15.9% | no data | |||
1,132,270 | US$65.0m | 52% | 0.02% | |||
1,005,470 | US$57.7m | -2.04% | 0.02% | |||
1,000,000 | US$57.4m | -57% | 1.45% | |||
836,283 | US$48.0m | 41.2% | 7.61% | |||
768,221 | US$44.1m | -34.4% | no data | |||
766,763 | US$44.0m | 25.8% | no data | |||
746,159 | US$42.8m | 6.23% | 0.41% | |||
740,861 | US$42.5m | -2.65% | no data | |||
627,089 | US$36.0m | 0% | 8.04% | |||
487,000 | US$27.9m | 26.5% | 1.14% | |||
436,146 | US$25.0m | -10.5% | 0.06% |